JP2009536193A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009536193A5 JP2009536193A5 JP2009509455A JP2009509455A JP2009536193A5 JP 2009536193 A5 JP2009536193 A5 JP 2009536193A5 JP 2009509455 A JP2009509455 A JP 2009509455A JP 2009509455 A JP2009509455 A JP 2009509455A JP 2009536193 A5 JP2009536193 A5 JP 2009536193A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- nicotine
- precursor
- derivative
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 8
- 239000004480 active ingredient Substances 0.000 claims 8
- 229960002715 nicotine Drugs 0.000 claims 8
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 8
- 239000002243 precursor Substances 0.000 claims 4
- 239000000411 inducer Substances 0.000 claims 3
- 230000000202 analgesic effect Effects 0.000 claims 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 206010062767 Hypophysitis Diseases 0.000 claims 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 claims 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 claims 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 claims 1
- 101710200814 Melanotropin alpha Proteins 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 210000003635 pituitary gland Anatomy 0.000 claims 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2006/000031 WO2007129879A1 (es) | 2006-05-08 | 2006-05-08 | EL USO DE LA NICOTINA, SUS ANÁLOGOS, SUS PRECURSORES O SUS DERIVADOS EN EL TRATAMIENTO DE DIVERSOS PROCESOS PATOLÓGICOS SUSCEPTIBLES DE MEJORAR CON α-MSH ADMINISTRADA EN FORMA PROFILÁCTICA O TERAPÉUTICA. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009536193A JP2009536193A (ja) | 2009-10-08 |
| JP2009536193A5 true JP2009536193A5 (enExample) | 2011-03-24 |
Family
ID=38667940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009509455A Pending JP2009536193A (ja) | 2006-05-08 | 2006-05-08 | 予防若しくは治療の形態で投与されるα−ＭＳＨを用いた、改善の余地のある多様な病理学的過程に関する治療におけるニコチン、そのアナログ、その前駆体またはその誘導体の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20090197921A1 (enExample) |
| EP (4) | EP2801359A3 (enExample) |
| JP (1) | JP2009536193A (enExample) |
| KR (1) | KR20130116374A (enExample) |
| CN (1) | CN101437515B (enExample) |
| AU (1) | AU2006343439B2 (enExample) |
| BR (1) | BRPI0621650A2 (enExample) |
| CA (1) | CA2651580C (enExample) |
| DK (1) | DK2801360T3 (enExample) |
| ES (1) | ES2683323T3 (enExample) |
| MX (1) | MX2008011473A (enExample) |
| NZ (1) | NZ572366A (enExample) |
| WO (1) | WO2007129879A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8557804B2 (en) | 2002-03-25 | 2013-10-15 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| US8039459B2 (en) * | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
| US20110206642A1 (en) * | 2009-10-15 | 2011-08-25 | Cohava Gelber | Preventing obesity-related metabolic syndrome with melagonesis |
| US9668969B1 (en) | 2012-02-22 | 2017-06-06 | Arturo Solis Herrera | Methods of using QIAPINE |
| CA2960583C (en) | 2014-09-09 | 2019-01-15 | Arturo Solis Herrera | Methods for treating and preventing ocular diseases, disorders, and conditions with melanin and melanin analogs, precursors, and derivatives |
| CA3014725C (en) * | 2016-04-12 | 2020-09-22 | Arturo Solis Herrera | Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists |
| LU101520B1 (en) * | 2019-12-02 | 2021-06-07 | Herrera Arturo Solis | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030185761A1 (en) * | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| US6610713B2 (en) * | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| CA2341952A1 (en) * | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
| SE0104388D0 (sv) * | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
| AU2005225458B2 (en) * | 2004-03-25 | 2008-12-04 | The Feinstein Institutes For Medical Research | Neural tourniquet |
-
2006
- 2006-05-08 ES ES14170573.1T patent/ES2683323T3/es active Active
- 2006-05-08 BR BRPI0621650-1A patent/BRPI0621650A2/pt not_active Application Discontinuation
- 2006-05-08 CN CN200680054519.1A patent/CN101437515B/zh not_active Expired - Fee Related
- 2006-05-08 AU AU2006343439A patent/AU2006343439B2/en active Active
- 2006-05-08 EP EP20140170572 patent/EP2801359A3/en not_active Withdrawn
- 2006-05-08 NZ NZ572366A patent/NZ572366A/en not_active IP Right Cessation
- 2006-05-08 CA CA2651580A patent/CA2651580C/en active Active
- 2006-05-08 EP EP14170571.5A patent/EP2801358A3/en not_active Withdrawn
- 2006-05-08 JP JP2009509455A patent/JP2009536193A/ja active Pending
- 2006-05-08 EP EP14170573.1A patent/EP2801360B1/en active Active
- 2006-05-08 EP EP06747531A patent/EP2027860A1/en not_active Ceased
- 2006-05-08 KR KR1020137025038A patent/KR20130116374A/ko not_active Withdrawn
- 2006-05-08 WO PCT/MX2006/000031 patent/WO2007129879A1/es not_active Ceased
- 2006-05-08 DK DK14170573.1T patent/DK2801360T3/en active
-
2008
- 2008-09-08 MX MX2008011473A patent/MX2008011473A/es active IP Right Grant
-
2009
- 2009-04-06 US US12/418,993 patent/US20090197921A1/en not_active Abandoned
-
2012
- 2012-06-27 US US13/534,710 patent/US20120270907A1/en not_active Abandoned
-
2015
- 2015-09-22 US US14/860,973 patent/US20160008347A1/en not_active Abandoned
-
2016
- 2016-06-08 US US15/176,555 patent/US20160279116A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
| JP2007522094A5 (enExample) | ||
| NO340679B1 (no) | Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer | |
| JP2007262090A5 (enExample) | ||
| JP2010535814A5 (enExample) | ||
| JP2005518433A5 (enExample) | ||
| JP2007513165A5 (enExample) | ||
| WO2007135193A3 (fr) | Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| JP2010534684A5 (enExample) | ||
| EA201071054A1 (ru) | Твердый препарат, растворяющийся во рту | |
| EP2081550A4 (en) | COATING OF CAPSULES WITH PHARMACEUTICAL ACTIVE SUBSTANCES | |
| ATE505203T1 (de) | Pharmazeutische kombination aus aliskiren und valsartan | |
| IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
| DK1931310T3 (da) | Monofasisk filmdannende sammensætning til topisk administration | |
| WO2007143163A3 (en) | Pharmaceutical compositions for sustained release of phenyephrine | |
| ZA200807027B (en) | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| JP2009536193A5 (enExample) | ||
| PL2101730T3 (pl) | Postać galenowa do podawania drogą przezśluzkową paracetamolu | |
| UY30126A1 (es) | Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones | |
| JP2008513426A5 (enExample) | ||
| GEP20125526B (en) | Drug active in neuropathic pain | |
| JP2009516719A5 (enExample) | ||
| EP2053038A4 (en) | AMINO ALCOHOL DERIVATIVE AND THESE IMMUNOSUP PRESSIVES CONTAINING ACTIVE INGREDIENTS |